Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Urothelial Cancer Screening in Individuals With Lynch Syndrome Using a Urine Tumor DNA Panel (LS-URO Study)

NCT06218433 is registered in ClinicalTrials.gov with Tampere University Hospital as lead sponsor.

NCT NCT06218433
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06218433 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Urothelial Cancer Screening in Individuals With Lynch Syndrome Using a Urine Tumor DNA Panel (LS-URO Study)
Lead sponsor
Tampere University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
April 10, 2023
Completion date
December 31, 2034
Enrollment
200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lynch syndrome, urothelial carcinoma